Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aurora Pryor

Surgery Stony Brook, NY Medical Doctor

NPI 1336223221 CMS profile 196464

Hsc 18 040, Stony Brook University Medical Center, Stony Brook, NY 11794

Open in the dashboard

General payments

$124,802

217 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aurora Pryor of Stony Brook, NY is reported in the CMS Open Payments database as having received $124,802 across 217 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,977 11
2024 General $17,523 29
2023 General $37,357 38
2022 General $18,211 46
2021 General $26,527 65
2020 General $16,036 14
2019 General $3,171 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aurora Pryor
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Aurora Pryor were reported at $5,977. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Aurora Pryor Surgery median Middle half National median
2019 $3,171 $253 $82–$1,521 $163
2020 $16,036 $131 $40–$706 $114
2021 $26,527 $168 $50–$904 $132
2022 $18,211 $224 $76–$1,218 $149
2023 $37,357 $253 $82–$1,255 $160
2024 $17,523 $279 $90–$1,381 $164
2025 $5,977 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $37,204 97 payments
  2. Stryker Corporation $34,404 26 payments
  3. W. L. Gore & Associates, Inc. $34,231 43 payments
  4. Medical Device Business Services, Inc. $9,159 6 payments
  5. Covidien LP $4,542 6 payments
  6. Intuitive Surgical, Inc. $2,660 17 payments
  7. Regeneron Pharmaceuticals, Inc. $948 1 payment
  8. Applied Medical Resources Corporation $750 2 payments
  9. Intra-Sana Laboratories $194 3 payments
  10. Novo Nordisk Inc $147 2 payments
  11. Other $562 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $66,294 30 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,905 16 payments
  3. Travel and Lodging $10,095 49 payments
  4. Food and Beverage $9,410 118 payments
  5. Honoraria $6,065 3 payments
  6. Education $32 1 payment
Products named General payments · program years 2019–2025
  1. GORE ENFORM Preperitoneal Biomaterial $21,533 9 payments
  2. GORE SYNECOR Biomaterial $21,488 9 payments
  3. 1688 $20,841 5 payments
  4. GORE BIO-A Tissue Reinforcement $19,722 11 payments
  5. SEAMGUARD Staple Line Reinforcement $15,195 6 payments
  6. SPY-PHI SYSTEM $13,150 12 payments
  7. LigaSure $10,334 20 payments
  8. S3 $9,500 4 payments
  9. Signia $7,600 43 payments
  10. GORE SEAMGUARD Bioabsorbable Staple Line Reinforce $7,071 7 payments
  11. Other $28,386 91 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$8,866

Medicare's payments for the services billed

Medicare patients

17

Average age 65

Services billed

41

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Heart failure 0%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RELTONE 200 MG
  • Intra-Sana Laboratories $25
$25 — —
GLYCATE
  • Intra-Sana Laboratories $25
$25 — —
RELTONE 400 MG
  • Intra-Sana Laboratories $25
$25 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

217 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record